Market Research

NA PCR-based Infectious Diseases Market - Industry Trends and Forecast to 2035

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 171 Pages Data Bridge Market Research February, 2024 DAABD18636646
Best Price Guarantee
Price from $3,500
Length 171 Pages
Publisher Data Bridge Market Research
Published Date February, 2024
SKU DAABD18636646

NA PCR-based Infectious Diseases Market - Industry Trends and Forecast to 2035


The North America PCR-based infectious diseases market is expected to reach USD 2,466,991.74 thousand by 2031 from USD 1,437,378.74 thousand in 2023, growing with a CAGR of 7.2% in the forecast period of 2024 to 2031.

Market Segmentation

North America PCR-based Infectious Diseases Market, By Test Type (Tuberculosis PCR Test, Hepatitis PCR Test, Human Immunodeficiency Virus (HIV) PCR Test, Influenza PCR Test, Human Papillomavirus (HPV) PCR Test, Gonorrhea PCT Test, Salmonellosis PCR Test, Rotavirus PCR Test, Bordetella PCR Test, H. Pylori PCR Test, Norovirus PCR Test, SARS (COVID-19) PCR Test, Enterococcus PCR Test, Chlamydia Trachomatis Genital PCR Test, C. Difficile (Clostridium Difficile) PCR Test, Carbapenem-Resistant Enterobacteriaceae (CRE) PCR Test, Mycoplasma Genitalium (MG) PCR Test, Methicillin-Resistant Staphylococcus Aureus (MRSA) PCR Test, and Other PCR Test), Infection (Viral Infection, Respiratory Tract Infection, Sexually Transmitted Infection, Hospital Acquired Infections, and Other Infections), Pathogen (Viral, Bacterial, Fungal, Protozoa, and Others), PCR Technology (RT PCR, Multiplex PCR, and Others), Patient Type (Geriatric, Pediatric, and Adults), Testing (Laboratory Based Testing and Point of Care Testing), End User (Diagnostic Centers, Hospital, Academic and Research Institutes, Community Health Centers, Clinics, Home Healthcare, and Others), Country (U.S., Canada, and Mexico) – Industry Trends and Forecast to 2031

Overview of North America PCR-based Infectious Diseases Market Dynamics

Driver
• Increasing PCR-based research activities

Restraint
• High cost of PCR test services

Opportunity
• Disease surveillance for early detection and monitoring of infectious diseases

Market Players

Some of the major market players operating in the North America PCR-based infectious diseases market are:
• DNA Labs India
• DrSafeHands
• Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
• Max Lab
• MicroGen Diagnostics
• pathlab
• The Washington Travel Clinic
• Clarewell Clinics
• AZOVA
• One Life Home Health Care Center
• LalPathLabs


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Pcr-based Infectious Diseases Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Test Type Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
5 Market Overview
5.1 Drivers
5.1.1 Increasing Pcr-based Research Activities
5.1.2 Rising Cases Of Infectious Diseases
5.1.3 Government Initiatives And Campaigns To Promote Disease Diagnosis
5.2 Restraints
5.2.1 High Cost Of Pcr Test Services
5.2.2 Shortage Of Skilled Laboratory Technicians
5.3 Opportunities
5.3.1 Disease Surveillance For Early Detection And Monitoring Of Infectious Diseases
5.3.2 Rising Innovations In Pcr Technology
5.3.3 Personalized Pcr-based Strategies For Targeted And Effective Interventions
5.4 Challenges
5.4.1 Data Security And Privacy Concerns
5.4.2 Complexity And Technical Expertise
6 North America Pcr-based Infectious Disease Market, By Test Type
6.1 Overview
6.2 Tuberculosis Pcr Test
6.3 Hepatitis Pcr Test
6.3.1 Hepatitis C Pcr Test
6.3.2 Hepatitis B Pcr Test
6.4 Human Immunodeficiency Virus (Hiv) Pcr Test
6.5 Influenza Pcr Test
6.6 Human Papillomavirus (Hpv) Pcr Test
6.7 Chlamydia Trachomatis Genital Pcr Test
6.8 Gonorrhea Pcr Test
6.9 Salmonellosis Pcr Test
6.10 Rotavirus Pcr Test
6.11 Bordetella Pcr Test
6.12 H. Pylori Pcr Test
6.13 Sars (Covid-19) Pcr Test
6.14 Norovirus Pcr Test
6.15 C.Difficile (Clostridium Difficile) Pcr Test
6.16 Carbapenem-resistant Enterobacteriaceae (Cre) Pcr Test
6.17 Enterococcus Pcr Test
6.18 Mycoplasma Genitalium (Mg) Pcr Test
6.19 Methicillin-resistant Staphylococcus Aureus (Mrsa) Pcr Test
6.20 Others Pcr Test
7 North America Pcr-based Infectious Diiseases Market, By Infection
7.1 Overview
7.2 Viral Infection
7.2.1 Sars (Covid-19) Infection
7.2.2 Rotavirus Infection
7.2.3 Norovirus Infection
7.2.4 Others
7.3 Respiratory Tract Infection
7.3.1 Influenza
7.3.2 Tuberculosis
7.3.3 Bordetella
7.4 Sexually Transmitted Infection
7.4.1 Chlamydia Trachomatis Genital Infection
7.4.2 Gonorrhea
7.4.3 Heaptitis
7.4.4 Human Immunodeficiency Virus (Hiv)
7.4.5 Human Papillomavirus (Hpv)
7.4.6 Mycoplasma Genitalium (Mg)
7.4.7 Others
7.5 Hospital Acquired Infections
7.5.1 C.Difficile (Clostridium Difficile)
7.5.2 Carbapenem- Resistant Enterobacteriaceae (Cre)
7.5.3 Methicilin- Resistant Staphylococcus Aureus (Mrsa)
7.5.4 Others
7.6 Other Infections
7.6.1 Salmonellosis
7.6.2 H. Pylori
7.6.3 Enterococcus Infections
7.6.4 Others
8 North America Pcr-based Infectious Diiseases Market, By Pathogen
8.1 Overview
8.2 Viral
8.3 Bacterial
8.4 Fungal
8.5 Protozoa
8.6 Others
9 North America Pcr-based Infectious Diiseases Market, By Pcr Technology
9.1 Overview
9.2 Rt Pcr
9.3 Multiplex Pcr
9.4 Others
10 North America Pcr-based Infectious Disease Market, By Patient Type
10.1 Overview
10.2 Geriatric
10.3 Pediatric
10.4 Adults
11 North America Pcr-based Infectious Disease Market, By Testing
11.1 Overview
11.2 Laboratory Based Testing
11.3 Point Of Care Testing
12 North America Pcr-based Infectious Diseases Market, By End User
12.1 Overview
12.2 Diagnostic Centers
12.3 Hospital
12.4 Clinics
12.5 Community Health Centers
12.6 Academic And Research Institutes
12.7 Home Healthcare
12.8 Others
13 North America Pcr-based Infectious Diseases Market, By Region
13.1 North America
13.1.1 U.S.
13.1.2 Canada
13.1.3 Mexico
14 North America Pcr-based Infectious Diseases Market: Company Landscape
14.1 Company Share Analysis: North America
15 Swot Analysis
16 Company Profile
16.1 Microgen Diagnostics
16.1.1 Company Snapshot
16.1.2 Service Portfolio
16.1.3 Recent Developments
16.2 Max Lab
16.2.1 Company Snapshot
16.2.2 Service Portfolio
16.3 Dna Labs India
16.3.1 Company Snapshot
16.3.2 Service Portfolio
16.3.3 Recent Development
16.4 Ganesh Diagnostic & Imaging Centre Pvt. Ltd.
16.4.1 Company Snapshot
16.4.2 Service Portfolio
16.4.3 Recent Development
16.5 Lalpathlabs
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Product Portfolio
16.5.4 Recent Developments
16.6 Azova
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Developments
16.7 Clarewell Clinics
16.7.1 Company Snapshot
16.7.2 Product Description
16.7.3 Recent Developments
16.8 Drsafehands
16.8.1 Company Snapshot
16.8.2 Service Portfolio
16.8.3 Recent Development
16.9 One Life Home Health Care Center
16.9.1 Company Snapshot
16.9.2 Product Description
16.9.3 Recent Developments
16.10 Pathlab
16.10.1 Company Snapshot
16.10.2 Service Portfolio
16.10.3 Recent Development
16.11 The Washington Travel Clinic
16.11.1 Company Snapshot
16.11.2 Service Portfolio
16.11.3 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables
Table 1 North America Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 2 North America Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 3 North America Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 4 North America Tuberculosis Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 5 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 6 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 7 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 8 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 9 North America Human Immunodeficiency Virus (Hiv) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 10 North America Influenza Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 11 North America Human Papillomavirus (Hpv) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 12 North America Chlamydia Trachomatis Genital Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 13 North America Gonorrhea Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 14 North America Salmonellosis Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 15 North America Rotavirus Pcr Test In Pcr Based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 16 North America Bordetella Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 17 North America H. Pylori Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 18 North America Sars (Covid-19) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 19 North America Norovirus Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 20 North America C.Difficile (Clostridium Difficile) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 21 North America Carbapenem-resistant Enterobacteriaceae (Cre) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 22 North America Enterococcus Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 23 North America Mycoplasma Genitalium (Mg) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 24 North America Methicillin-resistant Staphylococcus Aureus (Mrsa) Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 25 North America Others Pcr Test In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 26 North America Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 27 North America Viral Infection In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 28 North America Viral Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 29 North America Respiratory Tract Infection In Pcr-based Inffectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 30 North America Respiratory Tract Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 31 North America Sexually Transmitted Infection In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 32 North America Sexually Transmitted Infection In Viral Respiratory Infections Treatment Market, By Infection, 2022-2031 (Usd Thousand)
Table 33 North America Hospital Acquired Infections In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 34 North America Hospital Acquired Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 35 North America Other Infections In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 36 North America Other Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 37 North America Pcr-based Infectious Disease Market, By Pathogen, 2022-2031 (Usd Thousand)
Table 38 North America Viral In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 39 North America Bacterial In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 40 North America Fungal In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 41 North America Protozoa In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 42 North America Others In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 43 North America Pcr-based Infectious Disease Market, By Pcr Technology, 2022-2031 (Usd Thousand)
Table 44 North America Rt Pcr In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 45 North America Multiplex Pcr In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 46 North America Others In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 47 North America Pcr-based Infectious Disease Market, By Patient Type, 2022-2031 (Usd Thousand)
Table 48 North America Geriatric In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 49 North America Pediatric In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 50 North America Adults In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 51 North America Pcr-based Infectious Disease Market, By Testing, 2022-2031 (Usd Thousand)
Table 52 North America Laboratory Based Testing In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 53 North America Point Of Care Testing In Pcr-based Infectious Disease Market, By Region, 2022-2031 (Usd Thousand)
Table 54 North America Pcr-based Infectious Diseases Market, By End User, 2022-2031 (Usd Thousand)
Table 55 North America Diagnostic Centers In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 56 North America Hospital In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 57 North America Clinics In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 58 North America Community Health Centers In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 59 North America Academic And Research Institutes In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 60 North America Home Healthcare In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 61 North America Others In Pcr-based Infectious Diseases Market, By Region, 2022-2031 (Usd Thousand)
Table 62 North America Pcr-based Infectious Disease Market, By Country, 2022-2031 (Usd Thousand)
Table 63 North America Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 64 North America Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 65 North America Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 66 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 67 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 68 North America Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 69 North America Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 70 North America Viral Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 71 North America Respiratory Tract Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 72 North America Sexually Transmitted Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 73 North America Hospital Acquired Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 74 North America Other Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 75 North America Pcr-based Infectious Disease Market, By Pathogen, 2022-2031 (Usd Thousand)
Table 76 North America Pcr-based Infectious Disease Market, By Pcr Technology, 2022-2031 (Usd Thousand)
Table 77 North America Pcr-based Infectious Disease Market, By Patient Type, 2022-2031 (Usd Thousand)
Table 78 North America Pcr-based Infectious Disease Market, By Testing, 2022-2031 (Usd Thousand)
Table 79 North America Pcr-based Infectious Disease Market, By End User, 2022-2031 (Usd Thousand)
Table 80 U.S. Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 81 U.S. Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 82 U.S. Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 83 U.S. Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 84 U.S. Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 85 U.S. Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 86 U.S. Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 87 U.S. Viral Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 88 U.S. Respiratory Tract Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 89 U.S. Sexually Transmitted Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 90 U.S. Hospital Acquired Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 91 U.S. Other Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 92 U.S. Pcr-based Infectious Disease Market, By Pathogen, 2022-2031 (Usd Thousand)
Table 93 U.S. Pcr-based Infectious Disease Market, By Pcr Technology, 2022-2031 (Usd Thousand)
Table 94 U.S. Pcr-based Infectious Disease Market, By Patient Type, 2022-2031 (Usd Thousand)
Table 95 U.S. Pcr-based Infectious Disease Market, By Testing, 2022-2031 (Usd Thousand)
Table 96 U.S. Pcr-based Infectious Disease Market, By End User, 2022-2031 (Usd Thousand)
Table 97 Canada Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 98 Canada Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 99 Canada Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 100 Canada Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 101 Canada Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 102 Canada Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 103 Canada Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 104 Canada Viral Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 105 Canada Respiratory Tract Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 106 Canada Sexually Transmitted Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 107 Canada Hospital Acquired Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 108 Canada Other Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 109 Canada Pcr-based Infectious Disease Market, By Pathogen, 2022-2031 (Usd Thousand)
Table 110 Canada Pcr-based Infectious Disease Market, By Pcr Technology, 2022-2031 (Usd Thousand)
Table 111 Canada Pcr-based Infectious Disease Market, By Patient Type, 2022-2031 (Usd Thousand)
Table 112 Canada Pcr-based Infectious Disease Market, By Testing, 2022-2031 (Usd Thousand)
Table 113 Canada Pcr-based Infectious Disease Market, By End User, 2022-2031 (Usd Thousand)
Table 114 Mexico Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 115 Mexico Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 116 Mexico Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 117 Mexico Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Usd Thousand)
Table 118 Mexico Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Volume)
Table 119 Mexico Hepatitis Pcr Test In Pcr-based Infectious Disease Market, By Test Type, 2022-2031 (Asp)
Table 120 Mexico Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 121 Mexico Viral Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 122 Mexico Respiratory Tract Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 123 Mexico Sexually Transmitted Infection In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 124 Mexico Hospital Acquired Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 125 Mexico Other Infections In Pcr-based Infectious Disease Market, By Infection, 2022-2031 (Usd Thousand)
Table 126 Mexico Pcr-based Infectious Disease Market, By Pathogen, 2022-2031 (Usd Thousand)
Table 127 Mexico Pcr-based Infectious Disease Market, By Pcr Technology, 2022-2031 (Usd Thousand)
Table 128 Mexico Pcr-based Infectious Disease Market, By Patient Type, 2022-2031 (Usd Thousand)
Table 129 Mexico Pcr-based Infectious Disease Market, By Testing, 2022-2031 (Usd Thousand)
Table 130 Mexico Pcr-based Infectious Disease Market, By End User, 2022-2031 (Usd Thousand)
List Of Figures
Figure 1 North America Pcr-based Infectious Disease Market: Segmentation
Figure 2 North America Pcr-based Infectious Disease Market: Data Triangulation
Figure 3 North America Pcr-based Infectious Disease Market: Droc Analysis
Figure 4 North America Pcr-based Infectious Disease Market: North America Vs Regional Market Analysis
Figure 5 North America Pcr-based Infectious Disease Market: Company Research Analysis
Figure 6 North America Pcr-based Infectious Disease Market: Interview Demographics
Figure 7 North America Pcr-based Infectious Disease Market: Market Application Coverage Grid
Figure 8 North America Pcr Based Infectious Disease Market: Dbmr Market Position Grid
Figure 9 North America Pcr-based Infectious Disease Market: Vendor Share Analysis
Figure 10 North America Pcr-based Infectious Disease Market: Segmentation
Figure 11 The Government Initiatives And Campaigns To Promote Disease Diagnosis Is Driving The Growth Of The North America Pcr-based Infectious Disease Market From 2024 To 2031
Figure 12 The Infection Type Segment Is Expected To Account For The Largest Share Of The North America Pcr-based Infectious Disease Market In 2024 And 2031
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Pcr-based Infectious Diseases Market
Figure 14 North America Pcr-based Infectious Disease Market : By Test Type, 2023
Figure 15 North America Pcr-based Infectious Disease Market : By Test Type, 2024-2031 (Usd Thousand)
Figure 16 North America Pcr-based Infectious Disease Market : By Test Type, Cagr (2024-2031)
Figure 17 North America Pcr-based Infectious Disease Market : By Test Type, Lifeline Curve
Figure 18 North America Pcr-based Infectious Disease Market: By Infection, 2023
Figure 19 North America Pcr-based Infectious Disease Market: By Infection, 2024-2031 (Usd Thousand)
Figure 20 North America Pcr-based Infectious Disease Market: By Infection, Cagr (2024-2031)
Figure 21 North America Pcr-based Infectious Disease Market: By Infection, Lifeline Curve
Figure 22 North America Pcr-based Infectious Disease Market: By Pathogen, 2023
Figure 23 North America Pcr-based Infectious Disease Market: By Pathogen, 2024-2031 (Usd Thousand)
Figure 24 North America Pcr-based Infectious Disease Market: By Pathogen, Cagr (2024-2031)
Figure 25 North America Pcr-based Infectious Disease Market: By Pathogen, Lifeline Curve
Figure 26 North America Pcr-based Infectious Disease Market: By Pcr Technology, 2023
Figure 27 North America Pcr-based Infectious Disease Market: By Pcr Technology, 2024-2031 (Usd Thousand)
Figure 28 North America Pcr-based Infectious Disease Market: By Pcr Technology, Cagr (2024-2031)
Figure 29 North America Pcr-based Infectious Disease Market: By Pcr Technology, Lifeline Curve
Figure 30 North America Pcr-based Infectious Disease Market : By Patient Type, 2023
Figure 31 North America Pcr-based Infectious Disease Market : By Patient Type, 2024-2031 (Usd Thousand)
Figure 32 North America Pcr-based Infectious Disease Market : By Patient Type, Cagr (2024-2031)
Figure 33 North America Pcr-based Infectious Disease Market : By Patient Type, Lifeline Curve
Figure 34 North America Pcr-based Infectious Disease Market : By Testing, 2023
Figure 35 North America Pcr-based Infectious Disease Market : By Testing, 2024-2031 (Usd Thousand)
Figure 36 North America Pcr-based Infectious Disease Market : By Testing, Cagr (2024-2031)
Figure 37 North America Pcr-based Infectious Disease Market : By Testing, Lifeline Curve
Figure 38 North America Pcr-based Infectious Diseases Market: By End User, 2023
Figure 39 North America Pcr-based Infectious Diseases Market: By End User, 2024-2031 (Usd Thousand)
Figure 40 North America Pcr-based Infectious Diseases Market: By End User, Cagr (2024-2031)
Figure 41 North America Pcr-based Infectious Diseases Market: By End User, Lifeline Curve
Figure 42 North America Pcr-based Infectious Diseases Market: Snapshot (2023)
Figure 43 North America Pcr-based Infectious Diseases Market: Company Share 2023 (%)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings